Christine E. Thomas - Oct 10, 2022 Form 4 Insider Report for FEMASYS INC (FEMY)

Role
SVP, Regulatory & Clinical
Signature
/s/ Kathy Lee-Sepsick, Attorney-in-fact
Stock symbol
FEMY
Transactions as of
Oct 10, 2022
Transactions value $
$0
Form type
4
Date filed
10/17/2022, 04:48 PM
Next filing
Nov 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FEMY Stock Option (Right to Buy) Award $0 +50K $0.00 50K Oct 10, 2022 Common Stock 50K $1.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option vest equally in installments over 4 years beginning on October 10, 2023, provided that the reporting person is employed by the Issuer or a subsidiary of the Issuer on the vesting date.